vialroom
Fortnightly digest · 2026-03-23 → 2026-04-05

maintenance is now the busiest room in the building

The channel that nobody used in 2024 is now the highest volume channel here, which is the single clearest sign of what has happened to this room. Most of the traffic is people two or three years in, comparing what a maintenance dose actually looks like for them. There is still no trial data and the channel still says so weekly.

9.1Kmessages
290day logs
4channels noted
5notes

What happened

  • Maintenance overtook semaglutide by message volume for the first time, which the archivists checked twice before publishing.
  • The range of reported maintenance doses is enormous and shows no pattern anybody has been able to defend, which is itself informative.
  • Members holding lean mass through maintenance credited resistance training and protein intake far more than any dosing choice.
  • STEP 4 in JAMA 2021 continues to be the trial most often cited and most often misquoted, usually by people arguing for stopping abruptly.
  • A member three years in described the whole thing as unremarkable now, which several newer members found the most encouraging message of the fortnight.

Channels this fortnight

Most-reacted messages in this fortnight

Pulled from the logs, not hand-picked. Each links to the exact message.

Busiest logs in this fortnight

Topics touched